207_Combined course Presentations

Enrichment Design

• Primarily for settings where the classifier is based on a single gene whose protein product is the target of the drug – eg trastuzumab • Analytical validation, biological rationale and phase II data provide basis for regulatory approval of the test • Phase III study focused on test + patients to provide data for approving the drug